0 Bedömningar
ID

19898

Beskrivning

The purpose of this study is to determine the safety and efficacy of natalizumab in the treatment of individuals who have been diagnosed with relapsing remitting multiple sclerosis (MS). It is hoped that natalizumab will prevent certain types of white blood cells from moving out of the bloodstream into organs, including the brain, that are being damaged by autoimmune disease (a disease in which the body's own immune system attacks certain organs). These white blood cells are thought to cause inflammation that can result in lesions (small areas of damage) in the brain. These lesions are thought to be the cause of relapses and disability in MS.

Nyckelord

Versioner (1)
  1. 2017-01-30 2017-01-30 -
Uppladdad den

30 januari 2017

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

  • Senaste
  • Äldsta
  • Önskad
  • Senaste
    • Senaste
    • Äldsta
    • Önskad

    Inga kommentarer

    Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

    End of study CRFs Multiple Sklerosis Tysabri NCT00027300

    Engelsk

    End of study CRFs Multiple Sklerosis Tysabri NCT00027300

    1 Formulär  
    End of study
    Beskrivning

    End of study

    Alias
    UMLS CUI-1
    C0008976
    UMLS CUI-2
    C0444930
    Did the subject complete the study?
    Beskrivning

    Completion of study

    Datatyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0008976
    UMLS CUI [1,2]
    C1444661
    If "yes", mark the primary reason below
    Beskrivning

    Reason

    Datatyp

    text

    Alias
    UMLS CUI [1]
    C0392360
    Reason, why subject did not complete the study:
    Beskrivning

    Reason study not completed

    Datatyp

    integer

    Alias
    UMLS CUI [1,1]
    C0392360
    UMLS CUI [1,2]
    C0008976
    UMLS CUI [1,3]
    C0205257
    Description:
    Beskrivning

    Reason description

    Datatyp

    text

    Alias
    UMLS CUI [1,1]
    C0678257
    UMLS CUI [1,2]
    C0392360
    Tillbaka till toppen

    Similar models

    End of study CRFs Multiple Sklerosis Tysabri NCT00027300

    1 Formulär
    Name
    Typ
    Description | Question | Decode (Coded Value)
    Datatyp
    Alias
    Item Group
    End of study
    C0008976 (UMLS CUI-1)
    C0444930 (UMLS CUI-2)
    Completion of study
    Item
    Did the subject complete the study?
    boolean
    C0008976 (UMLS CUI [1,1])
    C1444661 (UMLS CUI [1,2])
    Reason
    Item
    If "yes", mark the primary reason below
    text
    C0392360 (UMLS CUI [1])
    Item
    Reason, why subject did not complete the study:
    integer
    C0392360 (UMLS CUI [1,1])
    C0008976 (UMLS CUI [1,2])
    C0205257 (UMLS CUI [1,3])
    reason study drug discontinued
    Code List
    Reason, why subject did not complete the study:
    CL Item
    Lost to follow-up (describe below) (1 )
    CL Item
    Adverse event(s) (complete Adverse Event form) (2 )
    CL Item
    Voluntary withdrawal for reasons other than Adverse Event (describe below) (3 )
    CL Item
    Subject was non-compliant (4 )
    CL Item
    Death (complete Record of Death form) (5 )
    CL Item
    Other (describe below) (6 )
    Reason description
    Item
    Description:
    text
    C0678257 (UMLS CUI [1,1])
    C0392360 (UMLS CUI [1,2])
    Tillbaka till toppen 

    Hjälp

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial